Atlas Journal of Biology

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Sample volume 1
Title Risk Factors Affecting the Phenotypic Expression of Heterozy­gous Familial Hypercholesterolemia in Pakistani Population
Author Fauzia Imtiaz, Wajahatullah Khan, Ahsan A. Vahidy
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism recognized by high plasma concentrations of low-density lipoprotein cholesterol (LDLC), tendon xanthomas, and high risk of early coronary heart disease. The phenotypic expression of FH is variable and several genetic and other risk factors contribute to such variability in clinical expression of the disease. FH is an autosomal disorder characterized by increased levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and tendinous xanthmata (TX). Clinical phenotype of FH has previously been shown to be associated with increased coronary heart disease (CHD) and premature death.  The present study was carried out in a Pakistani population to examine the contribution of environmental factors on the expression of this disease. A detailed examination of the physical and biochemical features of the FH was performed in a cohort of 335 individuals (202 males, 133 females) from Pakistan. Our results indicate that Pakistani females with FH had high levels of TC and LDL-C as compared to Pakistani males. Overall the concentrations of high density lipoprotein cholesterol (HDL-C) were significantly lower for both sexes as compared to the controls (normal). We have also found that high cholesterol levels were associated with increased incidence of CHD in FH Pakistani population where both male and female individuals showed 69% and 31% CHD, respectively. The mean onset age for coronary symptoms was about 38 years 
in males as compared to 45 years in females. A greater risk of developing CHD has been linked with levels of TC along with a history of smoking in males and presence of hypertension (HTN) in females. Our results indicate that these risk factors possibly affect and contribute in the phenotypic expression of FH in Pakistani population.
Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, 
Cruaud C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, 
Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc 
G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, 
Boileau C (2003) Mutations in PCSK9 cause autosomal dominant 
hypercholesterolemia. Nat Genet. 34: 154–156.
Alonso R, Defesche JC, Tejedor D, Castillo S,  Stef M, Mata N, GomezEnterria P, Martinez-Faedo C, Forga L,  Pedro Mata (2009) Genetic diagnosis of familial hypercholesterolemia using a DNA-array 
based platform. Clin Biochem. 42 (9): 899-903.
Austin MA, CM Hutter, RL Zimmern, and SE Humphries (2004) Familial 
hypercholesterolemia and coronary heart disease: a HuGE association review: Am J Epidemiol 160: 421-429.
Baron H, Fung S, Aydin A, Bahring S, Luft FC, Schuster H (1996) Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia. Nat Biotechnol. 14:1279–1282.
Bertolini S,  L Pisciotta, L Di Scala , S Langheim, A Bellocchio, P Masturzo, A Cantafora, S Martini, M Averna , G Pes, C Stefanutti, and S 
Calandra (2004) Genetic polymorphisms affecting the phenotypic 
expression of familial hypercholesterolemia. Atherosclerosis 174 
(1): 57-65. 
Castelli WP, RJ Garrison, PWF Wilson, RD Abbott, S. Kalousdian, and 
W. B. Kannel (1986)  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835-
Castro-Orós ID, Pocoví M, Civeira F (2010) The genetic basis of familial 
hypercholesterolemia: inheritance, linkage, and mutations.The Application of Clinical Genetics 3: 53–64
Civeira F (2004) International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management 
of heterozygous familial hypercholesterolemia. Atherosclerosis. 
Damgaard D, Jensen JM, Larsen ML, Soerensen VR, Jensen HK, Gre-gersen N, Jensen LG, Faergeman O (2004) No genetic linkage or 
molecular evidence for involvement of the PCSK9, ARH or CYP7A1 
genes in the familial hypercholesterolemia phenotype in a sample 
of Danish families without pathogenic mutations in the LDL receptor 
and apoB genes. Atherosclerosis. 177: 415–422.
Descamps OS, Leysen X, Van Leuven F, Heller FR. The use of Achilles 
tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2001;157:514–518.
Doll R, and AB Hill (1966) Mortality of British doctors in relation to 
smoking: observations on coronary thrombosis. J Natl Cancer Inst 
Monogr 19: 205-268. 
Fernando C (2004) Guidelines for the diagnosis and management of 
heterozygous familial hypercholesterolemia. Atherosclerosis 173: 
Friedewald WT, RI Levy, and DS Fredickson (1972) Estimation of the 
concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502.
Gagn´e C, Moorjani S, Brun D, Toussaint M, Lupien PJ. (1979) Heterozygous familial hypercholesterolemia. Relationship between plasma 
lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis 34:13–24.
Gardner CD, Marilyn AW, Stephen PF (2000) Population frequency distribution of non–high-density lipoprotein cholesterol (third national 
health and nutrition examination survey [NHANES iii], 1988–1994). 
Am J Cardiol 86: 299-304.
Goldstein JL, Brown MS (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells 
from a normal subject and from a patient with homozygous familial 
hypercholesterolemia. J Biol Chem 249: 5153-5162. 
Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR,, AL Beaudet, WS Sly, and D Vale (eds.) The 
metabolic and molecular bases of inherited disease, Vol. 120, New 
York, NY: McGraw-Hill Companies, Inc, pp. 2863-2914. 
Graham CA, McIlhatton BP, Kirk CW, Beattie ED, Lyttle K, Hart P, Neely 
RD, Young IS, Nicholls DP (2005) Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an 
improved mutation detection rate. Atherosclerosis 182: 331–340.
Hawe E, Talmud PJ, Miller GJ,  Humphries SE (2003) Family history is 
a coronary heart disease risk factor in the Second Northwick Park 
Heart Study. Ann Hum Genet 67: 97–106.
Heart and stroke facts. Dallas, TX (2001) American Heart Association. 
Hill JS, Hayden MR, Frohlich J, Pritchard PH (1991) Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler 
Thromb Vasc Biol 11(2): 290-297. 
Imtiaz F (2009) Estimation of heritability of familial hypercholesterolemia among 335 family members of five hypercholestrolemic probands of Pakstani population. J. Ayub Med Coll Abbottabad 21: 
Jansen ACM, Van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, 
Liem AH, Roeters van Lennep HWO, Sijbrands EJG,  Kastelein JJP 
(2004) The contribution of classical risk factors to cardiovascular 
disease in familial hypercholesterolemia: data in 2400 patients. J 
Intern Med 256: 482-490.
Junyent M, Gilabert R, Zambón D (2005) The use of Achilles tendon 
sonography to distinguish familial hypercholesterolemia from other 
genetic dyslipidemias. Arterioscler Thromb Vasc Biol. 25: 2203–
Kalina A, Csaszar A, Czeizel AE, Romics L, Szaboki F, Szalai C, Reiber 
I, Nemeth A, Stephenson S, Williams RR (2001) Frequency of the 
R3500Q mutation of the apolipoprotein B-100 gene in a sample 
screened clinically for familial hypercholesterolemia in Hungary. 
Atherosclerosis 154: 247–251. 
Kardia SL, SM Modell, PA Peyser (2003) Family-centered approaches 
to understanding and preventing coronary heart disease. Am J Prev 
Med 24: 143-151. 
Koivisto UM, Hamalainen L, Taskinen MR, Kettunen K, Kontula K (1993) 
Prevalence of familial hypercholesterolemia among young north 
Karelian patients with coronary heart disease: a study based on 
diagnosis by polymerase chain reaction. J Lipid Res. 34:269–277.
Koivisto UM, Turtola H, Aalto-Setala K, Top B, Frants R R, Kovanen P T, 
Syvänen A C, Kontula K (1992) The familial hypercholesterolemia 
(FH)-North Karelia mutation of the low density lipoprotein receptor 
gene deletes seven nucleotides of exon 6 and is a common cause of 
FH in Finland. J Clin Invest. 90:219–228.
Kotze MJ, Langenhoven E, Warnich L, du Plessis L, Retief AE (1991) The 
molecular basis and diagnosis of familial hypercholesterolaemia in 
South African Afrikaners. Ann Hum Genet. 55:115–121.
Kwiterovich PO (2008) Primary and secondary disorders of lipid metabolism in pediatrics. Pediatr Endocrinol Rev;5(Suppl 2):727-38.
Landsberger D, Meiner V, Reshef A , Levy Y, van der Westhuyzen DR, 
Coetzee GA, Leitersdorf E (1992) A nonsense mutation in the LDL 
receptor gene leads to familial hypercholesterolemia in the Druze 
sect. Am J Hum Genet. 50:427–433.
Lehrman MA, Russell DW, Goldstein JL, Brown MS (1987) Alu-Alu recombination deletes splice acceptor sites and produces secreted low 
density lipoprotein receptor in a subject with familial hypercholesterolemia. J Biol Chem. 262:3354–3361.
Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH (1990) Common lowdensity lipoprotein receptor mutations in the French Canadian population. J Clin Invest. 85:1014–1023.
Mabuchi H, Koizumi J, Shimizu M, Takeda R (1989) Development of 
coronary heart disease in familial hypercholesterolemia. Circulation. 
Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, Seftel HC, van 
der Westhuyzen DR, Jeenah MS, Coetzee GA, Leitersdorf  E (1991) 
A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet. 49:443–449.
Miettinen TA, Gylling H (1988) Mortality and cholesterol metabolism in 
familial hypercholesterolemia. Long-term follow-up of 96 patients. 
Arteriosclerosis. 8:163–167.
Müller C (1938) Xanthomata, hypercholesterolemia, angina pectoris: 
Acta Med Scand 89: 75–84. 
Neil HAW, V Seagroatt, DJ Betteridge,  M P Cooper, P N Durrington, 
J P Miller, M Seed, R P Naoumova, G R Thompson, R Huxley, and S 
E Humphries (2004) Established and emerging coronary risk factors 
in patients with heterozygous familial hypercholesterolemia. Heart 
90: 1431 – 1437.
Rader DJ, Cohen J, Hobbs HH (2003) Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest. 111: 
Rywik SL, AM Teri, P Andrzej, P Walerian, ED Clarence, BB Grazyna 
and K Ewa (1999)  Association of lipids and lipoprotein level with 
total mortality and morbidity caused by cardiovascular and cancer 
disease (Poland and United States Collaborative Study on Cardiovascular Epidemiology). Am J Cardiol 84: 540-548. 
Schuster H (2002) High risk/high priority: familial hypercholesterolemia 
–a paradigm for molecular medicine. Atheroscler Suppl. 2:27–30.
Tietz NW (1986) Textbook of Clinical Chemistry, Philadelphia, PA, WB, 
Saunders Co. pp. 888.
Torres AL, S Moorjani, MC Vohl, C Gagne, B Lamarche, LD Brun, PJ 
Lupien, and JP Despres (1996) Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational 
analysis and variation in the expression of plasma lipoprotein-lipid 
concentrations. Atherosclerosis 126 (1): 163-71.
Umans-Eckenhausen MA, EJ Sijbrands, JJ Kastelein, and JC Defesche (2002) Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. 
Circulation 106: 3031–3036.
Vuario AF, H Turtola, and KM Piilahti (1997) Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical and genealogical study. Arterioscler Thromb Vasc Biol 17: 3127-3138.
Weber M, S McNicoll, M Marcil, P Connelly, S Lussier-Cacan, J Davignon, Y Latour, and J Genest Jr (1997) Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein (a) and apolipoprotein E 
phenotypes in premature coronary artery disease in French Canadians. Can J Cardiol 13 (3): 253- 260.
Keywords Phenotypic expression, Familial hypercholesterolemia, Risk factors, Coronary heart disease, Smoking, Hypertension, Total Cholesterol, LDL-C
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Search in articles
Journal Published articles
AJB 31
Journal Hits
AJB 96902
Journal Downloads
AJB 230
Total users online -